Vargeese Chandra Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
11
Insider Sells Sum
$947,791.36

Insider Activity of Vargeese Chandra

According to the SEC Form 4 filings, Vargeese Chandra, being in a position of

  1. See Remarks at Wave Life Sciences Ltd.,
    оver the last 12 months, has bought 0 shares, and sold 3228 shares for $43,417,
    over all time since 2017-11-22, has bought 0 shares, and sold 80237 shares for $991,208.

Biography of Vargeese Chandra

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$43,4171100

Comparison of Insiders on Amount of Buys and Sells

2026-02-09SaleWave Life Sciences Ltd.
WVE
See Remarks
3,228
0.0017%
$13.45$43,417-56.11%
2023-02-16SaleWave Life Sciences Ltd.
WVE
See Remarks
10,249
0.0087%
$4.03$41,303-4.96%
2022-05-04SaleWave Life Sciences Ltd.
WVE
See Remarks
16,714
0.0223%
$1.72$28,748+106.19%
2022-02-16SaleWave Life Sciences Ltd.
WVE
Chief Technology Officer
10,603
0.014%
$2.32$24,599+18.28%
2021-02-16SaleWave Life Sciences Ltd.
WVE
Chief Technology Officer
3,145
0.0064%
$10.57$33,243-44.23%
2020-02-18SaleWave Life Sciences Ltd.
WVE
Senior VP, Drug Discovery
3,188
0.0087%
$7.85$25,026+9.67%
2019-12-03SaleWave Life Sciences Ltd.
WVE
Senior VP, Drug Discovery
12,000
0.0192%
$18.74$224,880-73.31%
2019-02-19SaleWave Life Sciences Ltd.
WVE
Senior VP, Drug Discovery
4,110
0.0123%
$36.84$151,412-34.15%
2018-09-24SaleWave Life Sciences Ltd.
WVE
Senior VP, Drug Discovery
6,000
0.0106%
$28.74$172,440-34.09%
2018-02-15SaleWave Life Sciences Ltd.
WVE
See Remarks
4,000
0.0072%
$26.24$104,960-17.05%
2018-01-23SaleWave Life Sciences Ltd.
WVE
See Remarks
4,000
0.0076%
$21.24$84,960+8.39%
2017-11-22SaleWave Life Sciences Ltd.
WVE
See Remarks
3,000
0.006%
$18.74$56,220+18.96%
Total: 12
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.